Interventional Oncology Market by Procedure - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 140 Category: Medical Devices Report Code : HC043219
Interventional Oncology Market by Procedure (Particle Embolization, Ablation, Radiation Therapy) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Interventional Oncology Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Interventional oncology strategies involve analysis and treatment of disease with the assistance of methods that are minimally invasive and directed under image direction. The procedure uses hardware, for example, ultrasound, x-ray, magnetic resonance imaging, or computed tomography for direction purposes. The techniques are done utilizing guide instruments and accessories, including removal cathodes, biopsy needles, guidewires, and intravascular catheters that empower the treatment of a tumor arranged in remote pieces of the body.
Drivers and Restraints
The developing interest for insignificantly intrusive therapeutics is the significant driving element for the market development. These systems could likewise be utilized to treat patients with other related comorbidities and in inoperable patients. The capacity of insignificantly intrusive procedures to treat dangerous cells superior to elective disease medicines, for example, radiation treatment, medical procedures, and methodical chemotherapy has helped the system gain prominence.
Regional Insights
Geographically, the market in North America is anticipated to flourish owing to advancement in technology and top notch medical procedures.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Accuray
- AtriCure
- Boston Scientific
- Medtronic
- Terumo Corporation
- Alpinion Medical Systems
- BTG
- Baylis Medical
- Merit Medical
- AngioDynamics
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Interventional Oncology Market, By Procedure, Estimates and Forecast, 2017-2027 ($Million)
o Particle Embolization
o Ablation
o Radiation Therapy
· Interventional Oncology Market, By Key Players
o Accuray
o AtriCure
o Boston Scientific
o Medtronic
o Terumo Corporation
o Alpinion Medical Systems
o BTG
o Baylis Medical
o Merit Medical
o AngioDynamics
· Interventional Oncology Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Interventional Oncology Market, By Country
o U.S. Interventional Oncology Market
o Canada Interventional Oncology Market
o Mexico Interventional Oncology Market
o Europe
§ Europe Interventional Oncology Market, By Country
o Germany Interventional Oncology Market
o UK Interventional Oncology Market
o France Interventional Oncology Market
o Russia Interventional Oncology Market
o Italy Interventional Oncology Market
o Rest of Europe Interventional Oncology Market
o Asia-Pacific
§ Asia-Pacific Interventional Oncology Market, By Country
o China Interventional Oncology Market
o Japan Interventional Oncology Market
o South Korea Interventional Oncology Market
o India Interventional Oncology Market
o Southeast Asia Interventional Oncology Market
o Rest of Asia-Pacific Interventional Oncology Market
o South America
§ South America Interventional Oncology Market
o Brazil Interventional Oncology Market
o Argentina Interventional Oncology Market
o Columbia Interventional Oncology Market
o Rest of South America Interventional Oncology Market
o Middle East and Africa
§ Middle East and Africa Interventional Oncology Market
o Saudi Arabia Interventional Oncology Market
o UAE Interventional Oncology Market
o Egypt Interventional Oncology Market
o Nigeria Interventional Oncology Market
o South Africa Interventional Oncology Market
o Rest of MEA Interventional Oncology Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Interventional Oncology Market, By Procedure
5.1. Introduction
5.2. Global Interventional Oncology Revenue and Market Share by Procedure (2017-2027)
5.2.1. Global Interventional Oncology Revenue and Revenue Share by Procedure (2017-2027)
5.3. Particle Embolization
5.3.1. Global Particle Embolization Revenue and Growth Rate (2017-2027)
5.4. Ablation
5.4.1. Global Ablation Revenue and Growth Rate (2017-2027)
5.5. Radiation Therapy
5.5.1. Global Radiation Therapy Revenue and Growth Rate (2017-2027)
6. Interventional Oncology Market, By Region
6.1. Introduction
6.2. Global Interventional Oncology Revenue and Market Share by Regions
6.2.1. Global Interventional Oncology Revenue by Regions (2017-2027)
6.3. North America Interventional Oncology by Countries
6.3.1. North America Interventional Oncology Revenue and Growth Rate (2017-2027)
6.3.2. North America Interventional Oncology Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Interventional Oncology by Countries
6.4.1. Europe Interventional Oncology Revenue and Growth Rate (2017-2027)
6.4.2. Europe Interventional Oncology Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Interventional Oncology by Countries
6.5.1. Asia-Pacific Interventional Oncology Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Interventional Oncology Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Interventional Oncology by Countries
6.6.1. South America Interventional Oncology Revenue and Growth Rate (2017-2027)
6.6.2. South America Interventional Oncology Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Interventional Oncology by Countries
6.7.1. Middle East and Africa Interventional Oncology Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Interventional Oncology Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Accuray
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. AtriCure
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Boston Scientific
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Medtronic
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Terumo Corporation
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Alpinion Medical Systems
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. BTG
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Baylis Medical
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. Merit Medical
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
7.10. AngioDynamics
7.10.1. Business Overview
7.10.2. Service Portfolio
7.10.3. Strategic Developments
7.10.4. Financial Overview
8. Global Interventional Oncology Market Competition, by Manufacturer
8.1. Global Interventional Oncology Financial Overview by Manufacturer (2017-2017)
8.2. Global Interventional Oncology Price By Region (2017-2017)
8.3. Top 5 Interventional Oncology Manufacturer Market Share
8.4. Market Competition Trend
9. Interventional Oncology Market Forecast (2017-2027)
9.1. Global Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Interventional Oncology Market Forecast by Regions (2017-2027)
9.2.1. North America Interventional Oncology Market Forecast (2017-2027)
9.2.1.1. United States Interventional Oncology Market Forecast (2017-2027)
9.2.1.2. Canada Interventional Oncology Market Forecast (2017-2027)
9.2.1.3. Mexico Interventional Oncology Market Forecast (2017-2027)
9.2.2. Europe Interventional Oncology Market Forecast (2017-2027)
9.2.2.1. Germany Interventional Oncology Market Forecast (2017-2027)
9.2.2.2. France Interventional Oncology Market Forecast (2017-2027)
9.2.2.3. UK Interventional Oncology Market Forecast (2017-2027)
9.2.2.4. Russia Interventional Oncology Market Forecast (2017-2027)
9.2.2.5. Italy Interventional Oncology Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Interventional Oncology Market Forecast (2017-2027)
9.2.3. Asia-Pacific Interventional Oncology Market Forecast (2017-2027)
9.2.3.1. China Interventional Oncology Market Forecast (2017-2027)
9.2.3.2. Japan Interventional Oncology Market Forecast (2017-2027)
9.2.3.3. Korea Interventional Oncology Market Forecast (2017-2027)
9.2.3.4. India Interventional Oncology Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Interventional Oncology Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Interventional Oncology Market Forecast (2017-2027)
9.2.4. South America Interventional Oncology Market Forecast (2017-2027)
9.2.4.1. Brazil Interventional Oncology Market Forecast (2017-2027)
9.2.4.2. Argentina Interventional Oncology Market Forecast (2017-2027)
9.2.4.3. Columbia Interventional Oncology Market Forecast (2017-2027)
9.2.4.4. Rest of South America Interventional Oncology Market Forecast (2017-2027)
9.2.5. Middle East and Africa Interventional Oncology Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Interventional Oncology Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Interventional Oncology Market Forecast (2017-2027)
9.2.5.3. Egypt Interventional Oncology Market Forecast (2017-2027)
9.2.5.4. Nigeria Interventional Oncology Market Forecast (2017-2027)
9.2.5.5. South Africa Interventional Oncology Market Forecast (2017-2027)
9.2.5.6. Turkey Interventional Oncology Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Interventional Oncology Market Forecast (2017-2027)
9.3. Interventional Oncology Market Forecast by Procedure (2017-2027)
9.3.1. Interventional Oncology Forecast by Procedure (2017-2027)
9.3.2. Interventional Oncology Market Share Forecast by Procedure (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Interventional Oncology Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Interventional Oncology Revenue and Revenue Share by Procedure (2017-2018)
Figure Global Particle Embolization Revenue and Growth Rate (2017-2018)
Figure Global Ablation Revenue and Growth Rate (2017-2018)
Figure Global Radiation Therapy Revenue and Growth Rate (2017-2018)
Table Global Interventional Oncology Revenue by Regions (2017-2018)
Figure North America Interventional Oncology Growth Rate (2017-2018)
Figure North America Interventional Oncology Revenue and Growth Rate (2017-2018)
Figure North America Interventional Oncology by Countries (2017-2018)
Figure North America Interventional Oncology Revenue (Million USD) by Countries (2017-2018)
Figure United States Interventional Oncology Growth Rate (2017-2018)
Figure United States Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Interventional Oncology Growth Rate (2017-2018)
Figure Canada Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Interventional Oncology Growth Rate (2017-2018)
Figure Mexico Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Interventional Oncology Growth Rate (2017-2018)
Figure Europe Interventional Oncology Revenue and Growth Rate (2017-2018)
Figure Europe Interventional Oncology by Countries (2017-2018)
Figure Europe Interventional Oncology Revenue (Million USD) by Countries (2017-2018)
Figure Germany Interventional Oncology Growth Rate (2017-2018)
Figure Germany Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Interventional Oncology Growth Rate (2017-2018)
Figure France Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Interventional Oncology Growth Rate (2017-2018)
Figure UK Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Interventional Oncology Growth Rate (2017-2018)
Figure Russia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Interventional Oncology Growth Rate (2017-2018)
Figure Italy Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Interventional Oncology Growth Rate (2017-2018)
Figure Rest of Europe Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Interventional Oncology Growth Rate (2017-2018)
Figure Asia-Pacific Interventional Oncology Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Interventional Oncology by Countries (2017-2018)
Figure Asia-Pacific Interventional Oncology Revenue (Million USD) by Countries (2017-2018)
Figure China Interventional Oncology Growth Rate (2017-2018)
Figure China Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Interventional Oncology Growth Rate (2017-2018)
Figure Japan Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Interventional Oncology Growth Rate (2017-2018)
Figure Korea Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Interventional Oncology Growth Rate (2017-2018)
Figure India Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Interventional Oncology Growth Rate (2017-2018)
Figure Southeast Asia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Interventional Oncology Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Interventional Oncology Growth Rate (2017-2018)
Figure South America Interventional Oncology Revenue and Growth Rate (2017-2018)
Figure South America Interventional Oncology by Countries (2017-2018)
Figure South America Interventional Oncology Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Interventional Oncology Growth Rate (2017-2018)
Figure Brazil Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Interventional Oncology Growth Rate (2017-2018)
Figure Argentina Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Interventional Oncology Growth Rate (2017-2018)
Figure Columbia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Interventional Oncology Growth Rate (2017-2018)
Figure Rest of South America Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Interventional Oncology Growth Rate (2017-2018)
Figure Middle East and Africa Interventional Oncology Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Interventional Oncology by Countries (2017-2018)
Figure Middle East and Africa Interventional Oncology Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Interventional Oncology Growth Rate (2017-2018)
Figure Saudi Arabia Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Interventional Oncology Growth Rate (2017-2018)
Figure United Arab Emirates Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Interventional Oncology Growth Rate (2017-2018)
Figure Egypt Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Interventional Oncology Growth Rate (2017-2018)
Figure Nigeria Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Interventional Oncology Growth Rate (2017-2018)
Figure South Africa Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Interventional Oncology Growth Rate (2017-2018)
Figure Turkey Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Interventional Oncology Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Interventional Oncology Revenue (Millions USD) and Growth Rate (2017-2018)
Table Accuray Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AtriCure Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boston Scientific Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medtronic Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Terumo Corporation Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alpinion Medical Systems Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BTG Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Baylis Medical Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merit Medical Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AngioDynamics Interventional Oncology Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Interventional Oncology Market Share by Manufacturer
Figure Global Interventional Oncology Revenue and Market Share by Manufacturer
Table Global Interventional Oncology Price by Region (2017-2017)
Figure Top 5 Interventional Oncology Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Interventional Oncology Revenue (Millions USD) and Growth Rate (2018-2025)
Table Interventional Oncology Market Forecast by Regions (2018-2025)
Figure North America Interventional Oncology Market Forecast (2018-2025)
Figure United States Interventional Oncology Market Forecast (2018-2025)
Figure Canada Interventional Oncology Market Forecast (2018-2025)
Figure Mexico Interventional Oncology Market Forecast (2018-2025)
Figure Europe Interventional Oncology Market Forecast (2018-2025)
Figure Germany Interventional Oncology Market Forecast (2018-2025)
Figure France Interventional Oncology Market Forecast (2018-2025)
Figure UK Interventional Oncology Market Forecast (2018-2025)
Figure Russia Interventional Oncology Market Forecast (2018-2025)
Figure Italy Interventional Oncology Market Forecast (2018-2025)
Figure Rest of Europe Interventional Oncology Market Forecast (2018-2025)
Figure Asia-Pacific Interventional Oncology Market Forecast (2018-2025)
Figure China Interventional Oncology Market Forecast (2018-2025)
Figure Japan Interventional Oncology Market Forecast (2018-2025)
Figure Korea Interventional Oncology Market Forecast (2018-2025)
Figure India Interventional Oncology Market Forecast (2018-2025)
Figure Southeast Asia Interventional Oncology Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Interventional Oncology Market Forecast (2018-2025)
Figure South America Interventional Oncology Market Forecast (2018-2025)
Figure Brazil Interventional Oncology Market Forecast (2018-2025)
Figure Argentina Interventional Oncology Market Forecast (2018-2025)
Figure Columbia Interventional Oncology Market Forecast (2018-2025)
Figure Rest of South America Interventional Oncology Market Forecast (2018-2025)
Figure Middle East and Africa Interventional Oncology Market Forecast (2018-2025)
Figure Saudi Arabia Interventional Oncology Market Forecast (2018-2025)
Figure United Arab Emirates Interventional Oncology Market Forecast (2018-2025)
Figure Egypt Interventional Oncology Market Forecast (2018-2025)
Figure Nigeria Interventional Oncology Market Forecast (2018-2025)
Figure South Africa Interventional Oncology Market Forecast (2018-2025)
Figure Turkey Interventional Oncology Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Interventional Oncology Market Forecast (2018-2025)
Figure Global Interventional Oncology Forecast by Procedure (2018-2025)
Figure Global Interventional Oncology Market Share Forecast by Procedure (2018-2025)
Figure Global Interventional Oncology Forecast by Procedure (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|